Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Novo Nordisk launches Wegovy in India, targets obesity treatment market, offers semaglutide-based weekly injection TOI Business Desk / TIMESOFINDIA.COM / Jun 24, 2025, 15:58 IST ...

Novo Nordisk announced in a news release Monday that it had pulled its semaglutide, Wegovy, from Hims & Hers, alleging it was selling compounded drugs as "personalized" versions to customers.

Danish pharmaceutical giant Novo Nordisk has officially launched its flagship obesity drug Wegovy (semaglutide) in India, announced Managing Director Vikrant Shrotriya on Tuesday. Wegovy is a ...

Danish pharmaceutical giant Novo Nordisk on Tuesday launched its highly anticipated weight-loss injection, Wegovy, in India, aiming to tap into the country’s growing demand for anti-obesity drugs. The ...

Novo Nordisk is preparing to launch Wegovy in India, where millions of people are battling obesity and demand for the weight-loss drug is expected to be massive. The drug will be launched in ...

Hims & Hers stock fell 35% after Novo Nordisk ended their partnership on Monday. Novo Nordisk stopped the deal because Hims sold a cheaper version of Wegovy. Hims' stock has fluctuated with ...

Hims has also continued to sell "personalized" doses of compounded semaglutide -- the main active ingredient in Wegovy -- for $165 per month, according to its website.

Novo Nordisk alleged that Hims & Hers is putting patient safety at risk by selling compounded versions of Wegovy. Novo's ending of its deal with Hims & Hers jeopardizes the healthcare platform's ...

Novo Nordisk Ends Alliance with Hims & Hers Over Controversial Wegovy Sales Novo Nordisk has terminated its partnership with Hims & Hers Health for the distribution of its Wegovy weight-loss drug, ...

Novo Nordisk announced it would terminate its Wegovy weight-loss drug agreement with Hims & Hers Health, causing a significant drop in Hims shares. The end of this collaboration stems from legal ...